ImQuest Pharmaceuticals

ImQuest Pharmaceuticals is a biotechnology company and contract research organization (CRO) specializing in the development of therapeutics for infectious diseases, oncology, and inflammatory disorders. The company operates through its ImQuest BioSciences division to provide specialized laboratory services, while its pharmaceutical arm focuses on internal drug development programs. ImQuest is a leader in the development of topical microbicides for the prevention of HIV and other sexually transmitted infections. Their proprietary ImQuestSUCCESS platform integrates medicinal chemistry, drug delivery, and biological evaluation to accelerate the transition of compounds from discovery to the clinic. The company's portfolio includes novel small molecules targeting viral replication and entry, as well as innovative delivery systems like intravaginal rings and films.